Urological cancer, Malmö
141 – 150 of 554
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2022 Update
- Contribution to journal › Scientific review
-
Mark
Reply to Wei Zhang So, Ziting Wang, and Ho Yee Tiong's Letter to the Editor re : Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up. Eur Urol 2021;80:650–60
- Contribution to journal › Letter
- 2021
-
Mark
Quality of life with pharmacological treatment in patients with benign prostatic enlargement : results from the Evolution European Prospective Multicenter Multi-National Registry Study
- Contribution to journal › Article
-
Mark
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
- Contribution to journal › Article
-
Mark
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
- Contribution to journal › Article
-
Mark
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
- Contribution to journal › Scientific review
-
Mark
Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer : Data from the Prostate Cancer Registry
- Contribution to journal › Article
-
Mark
The Value of a New Diagnostic Test for Prostate Cancer : A Cost-Utility Analysis in Early Stage of Development
- Contribution to journal › Article
-
Mark
Systematic Review of the Role of BCG in the Treatment of Urothelial Carcinoma of the Prostatic Urethra
- Contribution to journal › Scientific review
-
Mark
A retrospective study assessing the accuracy of [18F]–fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node dissection
- Contribution to journal › Article
